[68Ga]Ga-A9T-3202

N/A

Report date: 2025/11/28 15:16:49

NME

Base Information

Drug Name[68Ga]Ga-A9T-3202

Drug Alias Name[68Ga]Ga-A9T-3202

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agent +[5]

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsUveal melanomaMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAlpha-9 Oncology USA Inc

China Registration ClassN/A

Develop Information

Active CompaniesAlpha-9 Oncology USA Inc

Inactive CompaniesN/A

Active IndicationsUveal melanomaMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A